Elsevier secures publishing rights for premium titles for 2023

Elsevier, a leading scientific publisher, and global information analytics business specializing in science and health, announced today that it will be the new publisher of six influential society journals starting in January 2023:

• American Journal of Clinical Nutrition

• The Journal of Nutrition

• Journal of Thrombosis and Haemostasis

• American Journal of Transplantation

• Laboratory Investigation

• Modern Pathology

The newly acquired titles represent the following societies and add to Elsevier’s expansive global health publishing portfolio:

• American Society for Nutrition (ASN)

• United States and Canadian Academy of Pathology (USCAP)

• International Society on Thrombosis and Haemostasis (ISTH)

• The American Society of Transplant Surgeons (ASTS)

• American Society of Transplantation (AST)

All are considered internationally renowned sources of knowledge and impactful study in the fields of pathology, nutrition, transplantation, haematology and peripheral vascular disease.

“It is an honor to partner with five established societies that have trusted Elsevier as the official publisher of their important journals. True to our commitment to supporting research and clinical practice, we are dedicated to placing our full range of industry-leading resources for authors, editors, reviewers and readers, in the disposal of our latest additions. With our continuous support and seamless collaboration these six valued titles can harness the benefits of a reliable global publishing partner allowing them to maximize their contribution to scientific research and clinical practice in their respective fields” said Carl Schwarz Senior Vice President, Health and Medical Sciences, at Elsevier. Elsevier will officially welcome the journals into their portfolio beginning in January 2023. They will be part of Elsevier’s title-by-title subscription model instead of a collection.

Learn more about these exceptional titles or contact us for more information.

엘스비어 소개

엘스비어는 첨단 정보와 의사결정 지원 분야의 글로벌 선도 기업으로 100년 넘게 과학과 헬스케어의 발전을 지원하며 인류 진보에 기여해 왔습니다. 우리는 170개국 이상에서 학술 및 기업 연구 커뮤니티, 의사, 간호사, 미래의 의료 전문가와 교육자들을 지원합니다. 근거에 기반한 신뢰할 수 있는 과학·의학 콘텐츠와 최첨단 AI 기술을 결합해 중요한 통찰과 혁신적인 솔루션을 제공해, 의미있는 성과를 이루도록 돕고 있습니다. 또한 다양성과 지속 가능성을 제품과 기업 문화 전반에 내재화하며, 우리가 속한 커뮤니티와 협력합니다. 엘스비어 재단opens in new tab/window은 전 세계에서 연구와 보건 파트너십을 지원합니다.

엘스비어는 전문가 및 기업 고객에게 정보 기반의 분석과 의사결정 도구를 제공하는 글로벌 기업 RELXopens in new tab/window의 일원입니다. 자세한 내용은 www.elsevier.com에서 확인할 수 있으며, 소셜미디어 @elsevierconnect를 통해 최신 소식을 받아보실 수 있습니다.